State of Vermont Reached $450M Settlement with Opiate Maker, Endo International
Coming on the heels of a year of record-breaking overdose deaths, the state of Vermont announced Wednesday a national $450 million “agreement in principle” settlement with Endo International, an Irish drug-maker with U.S. headquarters in Pennsylvania.
“Every Vermonter has been touched in some way by the opioid crisis,” said Attorney General Susanne Young in a statement announcing the settlement. “No settlement amount will ever be enough. The Attorney General’s Office will continue to do everything in its power to hold the bad actors who promoted and profited from this crisis accountable.”
The Endo agreement marks the third such agreement the Attorney General’s Office has reached with opioid makers since July, when it announced agreements in principle with Teva and Allergan. To date, the office has negotiated more than $100 million in opioid settlements for Vermont, the office reported.
